But during the progression from obesity to diabetes, galectin-9 could upregulate and trigger phosphorylation of Tyr256 and Tyr263 by the tyrosine kinase ITK, thereby allowing TIM3 to exert the inhibitory function. This evidence concerns the gene HAVCR2 and obesity disorder.